Sanofi picked up Blueprint Medicines in a deal worth up to $9.5 billion. Bristol Myers Squibb will pay $1.5 billion upfront ...

Eli Lilly's (NYSE: LLY) share price soared during the first Trump administration. That momentum continued with Joe Biden in the White House. However, it's a much different story so far in Trump's ...

Eli Lilly: "I just think this is a decent level to start a position if you don't have any [buy, buy, buy!]." Navitas: "That one's done...I say take your money out that you put in and then you can ...

Eli Lilly: "I just think this is a decent level to start a position if you don't have any [buy, buy, buy!]." Stream Connecticut News for free, 24/7, wherever you are. Navitas: "That one's done ...

Eli Lilly: "I just think this is a decent level to start a position if you don't have any [buy, buy, buy!]." Stream NBC 5 for free, 24/7, wherever you are. Navitas ...

Eli Lilly: "I just think this is a decent level to start a position if you don't have any [buy, buy, buy!]." Stream San Diego News for free, 24/7, wherever you are with NBC 7. Navitas ...

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...

Eli Lilly (NYSE: LLY) is one of the undisputed leaders in developing anti-obesity medicines, with Novo Nordisk (NYSE: NVO) being its biggest challenger. Over the past six months, Eli Lilly has ...

Cigna’s Evernorth has reached new deals with manufacturers Eli Lilly and Novo Nordisk to cap ... burden of the drugs to cover the medications. Pharmacy middlemen like Cigna subsidiary Evernorth ...

Novo Nordisk would not comment on the new pharmacy benefits arrangements. But a spokesperson for Eli Lilly told CNBC, "Lilly will continue to work with those in health care, government and the ...